Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Tivic Health Systems, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
Fr | Tivic Health Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
08.07. | Tivic Health stock rises after shareholders approve strategic proposals | 1 | Investing.com | ||
TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
07.07. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
25.06. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
06.06. | Tivic Health Systems files to sell 8.44M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
06.06. | Tivic Health Systems, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
22.05. | Tivic Health Systems, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
16.05. | Tivic Health signals strategic transformation with $8.4M financing and biopharma focus amid market repositioning | 1 | Seeking Alpha | ||
15.05. | Tivic Health Systems, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
14.05. | Tivic Health partners with Scorpius for drug manufacturing | 2 | Investing.com | ||
14.05. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | Tivic adds new vagus nerve stim patent | 1 | MassDevice | ||
09.05. | Tivic Health Systems files to sell 292,523 shares of common stock for holders | 3 | Seeking Alpha | ||
09.05. | Tivic Health Systems, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
02.05. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
22.04. | Tivic Health-Aktien steigen aufgrund von Interesse an Verteidigungsanwendungen | 10 | Investing.com Deutsch | ||
22.04. | Tivic Health shares soar on defense application interest | 2 | Investing.com | ||
22.04. | Tivic Health briefs White House, FDA on biotech programs | 2 | Investing.com | ||
22.04. | Tivic Health informiert Weißes Haus und FDA über Biotech-Programme | 3 | Investing.com Deutsch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,118 | -6,35 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,690 | -2,68 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
PING AN HEALTHCARE | 1,070 | -0,37 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,011 | -22,97 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,250 | +5,04 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,840 | +4,09 % | A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts | ||
VERU | 0,491 | +2,46 % | VERU INC. - 8-K, Current Report | ||
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
VOLITIONRX | 0,750 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
EKSO BIONICS | 4,800 | +1,69 % | Preview: Ekso Bionics Holdings' Earnings | ||
IMUNON | 0,432 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS15117N6022 Imunon Inc. 24.07.2025 US15117N7012 Imunon Inc. 25.07.2025 Tausch 15:1US92511W1080 Verrica Pharmaceuticals... ► Artikel lesen | |
BEYOND AIR | 3,240 | -2,41 % | Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc. | GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,453 | -1,41 % | Novacyt S.A. - Launch of LightBench® Discover | ||
AROVELLA THERAPEUTICS | 0,051 | -5,61 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |